| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |